JAGX 8-K 2026-11-06

Jaguar Health, Inc. (JAGX) 8-K dated 2026-11-06 — accession 0001193125-26-451933.

Jaguar Health, Inc. (JAGX) is a biotechnology company listed on NASDAQ.

Jaguar Health, Inc. filed a 8-K on 2026-11-06. Accession 0001193125-26-451933.

This 8-K covers: Shareholder vote results (Item 5.07), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported JAGX revenue for 2025-12-31 was $11.5M. Net income was -$53.6M. Revenue was down 1.5% from 2024-12-31 to 2025-12-31. JAGX currently screens at market cap $1.7M.

Not investment advice. The JAGX SEC hub lists recent forms. The stock page is the research view.